XML 29 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Note 15 - Share-based Compensation (Tables)
3 Months Ended
Dec. 31, 2019
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Three months ended
 
   
December 31, 2019
 
Volatility
 
40.2%
 
Risk-free interest rate
 
1.5%
 
Forfeiture rate
 
10.0%
 
Dividend yield
 
0.0%
 
Expected life in years
 
5.0
 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
   
Number of
Shares
   
Weighted
Average Grant
Date Fair Value
 
Outstanding September 30, 2019
   
274,849
    $
2.59
 
Granted
   
-
    $
-
 
Released
   
-
    $
-
 
Forfeited/cancelled
   
(2,222
)   $
2.50
 
Outstanding December 31, 2019
   
272,627
    $
2.60
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
Number of
Shares
   
Weighted
Average
Exercise Price
 
Outstanding September 30, 2019
   
2,219,268
    $
1.94
 
Granted
   
333,727
    $
3.40
 
Forfeited/expired
   
(187,500
)   $
1.99
 
Exercised
   
(83,343
)   $
1.73
 
Outstanding December 31, 2019
   
2,282,152
    $
2.17
 
Exerciseable December 31, 2019
   
1,539,220
    $
1.97
 
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
       
 
 
 
 
Weighted Average
   
Weighted Average
   
 
 
 
 
Weighted Average
 
Range of
 
Number
   
Remaining
   
Exercise
   
Number
   
Exercise
 
Exercise Prices
 
Outstanding
   
Contractual Life
   
Price
   
Exercisable
   
Price
 
$1.31
-
$1.76
   
584,533
   
2.91
    $
1.65
     
531,220
    $
1.65
 
$1.86
-
$1.86
   
130,142
   
2.96
    $
1.86
     
130,142
    $
1.86
 
$1.99
-
$1.99
   
937,500
   
3.58
    $
1.99
     
562,500
    $
1.99
 
$2.02
-
$3.40
   
629,977
   
4.35
    $
2.97
     
315,358
    $
2.97
 
 
 
 
   
2,282,152
   
3.59
    $
2.17
     
1,539,220
    $
1.97
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   
Three months ended
 
   
December 31,
 
   
2019
   
2018
 
Cost of revenues
  $
3,642
    $
4,298
 
Selling, general, and administrative
   
143,927
     
111,851
 
Research and development
   
10,758
     
17,696
 
    $
158,327
    $
133,845